Intuitive Code AI urges selling short Bluebird Bio (BLUE), betting against Goldman Sachs. Bluebird Bio (BLUE) is Intuitive Code's number-one biotech investing idea for short-sellers.

We're selling shares of Bluebird Bio, downgrading to sell in real-time at $217, while Goldman Sachs is upgrading to $309. Bluebird Bio is likely to report an astonishing earnings miss next quarter. Short sellers are looking at a multi-million profit going into 2018.

Sell Bluebird Bio Ahead of the Collapse.

 
Bluebird Bio is the biotech stock to sell today on analysts' upgrades! According to AI research and analysis, the biotech company will report a remarkable loss in the following earnings report.
 

Best Biotechnology Advisor Downgrades bluebird bio $217 to Sell by IntuitiveCode on TradingView.com

Alex Vieira: I'm Selling Short Bluebird bio: No Risk!

 
Goldman Sachs raising price target on bluebird bio is the kiss of death.
 
Goldman Sachs has no credibility or track record in the biotech sector.